Certainly! Here's the cleaned-up description with all links and additional text removed: --- Leo was at ifa last week and Netgear was on his list of companies to visit - he got a look at the Meural ...

The FDA has started a priority review of X4 Pharma’s mavorixafor, angling to become the first therapy for the rare disease WHIM syndrome, with a decision due by 30th April next year. WHIM (warts, ...

This profile has not been claimed by the company. See reviews below to learn more or submit your own review. NETGEAR develops networking hardware and solutions. The company's product lineup includes ...

Originally hailing from Troy, Ohio, Ry Crist is a writer, a text-based adventure connoisseur, a lover of terrible movies and an enthusiastic yet mediocre cook. A CNET editor from 2013 to 2024, Ry's ...